dermatology

News

Ascletis says oral acne drug shows "exceptional efficacy"

Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US.

News

InflaRx stock halves after it drops lead drug

InflaRx has abandoned its drug development programme, vilobelimab for rare skin disease pyoderma gangrenosum, cratering its share price.

News

a person's arm with skin lesion triaging tool against the skin

Skin Analytics' dermatology AI backed for NHS use

An AI-powered tool for triaging patients with suspicious skin lesions, developed by Skin Analytics, will be used by the NHS to reduce waiting times.

News

J&J shows its confidence in oral IL-23 drug for psoriasis

J&J wants to turn the screw in the psoriasis market with a new head-to-head trial pitting oral IL-23 drug icotrokinra against Stelara.

News

AstraZeneca builds in China as Cosette buys Mayne

The reporting week has ended with a flurry of M&A as Cosette Pharma and AstraZeneca agree takeover deals.

News

Galderma adds new indication for blockbuster hope Nemluvio

Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to its label.

Ascletis says oral acne drug shows "exceptional efficacy"

InflaRx stock halves after it drops lead drug

Skin Analytics' dermatology AI backed for NHS use

J&J shows its confidence in oral IL-23 drug for psoriasis

AstraZeneca builds in China as Cosette buys Mayne

Galderma adds new indication for blockbuster hope Nemluvio

Padcev/Keytruda scores again in early bladder cancer

How to meet your physicians where they are online

dermatology

Editor's Picks